DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Receives Consensus Recommendation of “Hold” from Brokerages

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) has earned an average rating of “Hold” from the fourteen analysts that are currently covering the stock, Marketbeat.com reports. Three equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and three have given a buy rating to the company. The average 1 year price target among brokers that have updated their coverage on the stock in the last year is $13.31.

XRAY has been the subject of several research analyst reports. BMO Capital Markets dropped their price objective on DENTSPLY SIRONA from $13.00 to $10.00 and set a “market perform” rating for the company in a research note on Thursday, September 17th. Piper Sandler boosted their target price on DENTSPLY SIRONA from $13.00 to $14.00 and gave the stock a “neutral” rating in a research report on Wednesday, July 29th. Barrington Research set a $15.00 target price on DENTSPLY SIRONA in a report on Monday, August 10th. Weiss Ratings restated a “sell (e+)” rating on shares of DENTSPLY SIRONA in a research report on Monday, August 3rd. Finally, Barclays lifted their price target on DENTSPLY SIRONA from $9.00 to $11.00 and gave the stock an “underweight” rating in a research note on Monday, August 24th.

DENTSPLY SIRONA Stock Down 0.8%

XRAY stock opened at $8.67 on Friday. The company has a current ratio of 1.63, a quick ratio of 1.07 and a debt-to-equity ratio of 1.48. The company’s 50-day moving average price is $11.10 and its 200 day moving average price is $11.24. DENTSPLY SIRONA has a 52 week low of $8.59 and a 52 week high of $14.76. The company has a market cap of $1.73 billion, a P/E ratio of -3.15, a P/E/G ratio of 1.10 and a beta of 0.87.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its earnings results on Thursday, August 6th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.35 by $0.17. DENTSPLY SIRONA had a negative net margin of 14.99% and a positive return on equity of 20.84%. The company had revenue of $898.00 million during the quarter, compared to analysts’ expectations of $889.93 million. During the same period last year, the company posted $0.52 earnings per share. The firm’s quarterly revenue was down 4.1% compared to the same quarter last year. DENTSPLY SIRONA has set its FY 2026 guidance at 1.400-1.500 EPS. On average, research analysts expect that DENTSPLY SIRONA will post 1.4 earnings per share for the current fiscal year.

Hedge Funds Weigh In On DENTSPLY SIRONA

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in XRAY. Eurizon Capital SGR S.p.A. purchased a new stake in shares of DENTSPLY SIRONA in the fourth quarter valued at $26,000. Nykredit A S acquired a new stake in shares of DENTSPLY SIRONA during the 2nd quarter worth about $38,000. Performa Ltd US LLC boosted its stake in shares of DENTSPLY SIRONA by 116.1% during the 4th quarter. Performa Ltd US LLC now owns 4,250 shares of the medical instruments supplier’s stock worth $49,000 after purchasing an additional 2,283 shares during the last quarter. Huntington National Bank grew its holdings in shares of DENTSPLY SIRONA by 68.3% during the fourth quarter. Huntington National Bank now owns 4,689 shares of the medical instruments supplier’s stock worth $54,000 after buying an additional 1,903 shares in the last quarter. Finally, Allworth Financial LP acquired a new position in shares of DENTSPLY SIRONA in the second quarter valued at approximately $51,000. Institutional investors and hedge funds own 95.70% of the company’s stock.

About DENTSPLY SIRONA

Dentsply Sirona is a global dental products and technologies company that develops, manufactures and markets solutions for dental professionals, laboratories and patients. Its portfolio includes consumable products, dental equipment and digital technologies used in preventive, restorative, endodontic, orthodontic, implant and prosthetic dentistry.

The company offers dental treatment centers, imaging systems, CAD/CAM systems, intraoral scanners, milling and 3D-printing solutions, instruments, endodontic files and equipment, restorative materials, dental implants, prosthetic components and orthodontic products.